APA

François K. O., Auwerx J., Schols D. & Balzarini J. (20080822). Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. : Molecular pharmacology.

Chicago

François Katrien O, Auwerx Joeri, Schols Dominique and Balzarini Jan. 20080822. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. : Molecular pharmacology.

Harvard

François K. O., Auwerx J., Schols D. and Balzarini J. (20080822). Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. : Molecular pharmacology.

MLA

François Katrien O, Auwerx Joeri, Schols Dominique and Balzarini Jan. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. : Molecular pharmacology. 20080822.